Xu Li
About
In The Last Decade
Xu Li
417 papers receiving 8.9k citations
Hit Papers
Peers
Comparison fields: 5 of 195
- Molecular Biology 4.7k
- Cancer Research 1.5k
- Biomedical Engineering 817
- Immunology 781
- Oncology 730
Countries citing papers authored by Xu Li
This map shows the geographic impact of Xu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Li more than expected).
Fields of papers citing papers by Xu Li
This network shows the impact of papers produced by Xu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Li. The network helps show where Xu Li may publish in the future.
Co-authorship network of co-authors of Xu Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xu Li. A scholar is included among the top collaborators of Xu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Li. Xu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 10 | |
| 4 | 0 | |
| 5 | 23 | |
| 6 | 41 | |
| 7 | 1 | |
| 8 | 3 | |
| 9 | 12 | |
| 10 | 26 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 1 | |
| 14 | 3 | |
| 15 | Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer | 1 |
| 16 | miR-31 Modulates Liver Cancer HepG2 Cell Apoptosis and Invasion via ROCK1/F-Actin Pathways | 2 |
| 17 | Characterization of a novel blaNDM-5-harboring IncFII plasmid and an mcr-1-bearing IncI2 plasmid in a single Escherichia coli ST167 clinical isolate | 1 |
| 18 | 39 | |
| 19 | 17 | |
| 20 | 49 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.